Search - tctmd.com

Displaying 441 - 460 of 642

Sort: Relevancy | Date

News Daily News

La Mayoría de los Operadores siguen Escrutando Lesiones Intermedias a Pesar de las Recomendaciones en materia de FFR

November 17, 2014

Presentation

Revascularization Decisions in Patients With Stable Angina and Intermediate Lesions

Presenter: G.G. Toth

November 11, 2014

News Daily News

Real-World Study Shows Benefits of Treating Culprit Vessel Only in STEMI

Yael L. Maxwell

November 06, 2014

News Daily News

Model Identifies FFR-Deferred Lesions at Increased Risk of Revascularization Within 1 Year

November 02, 2014

News Daily News

Restenosis at Routine Angiographic Follow-up Predicts Long-term Mortality After PCI

L.A. McKeown

October 24, 2014

News Features

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

News Daily News

缺血检测可预示患有无症状CAD的糖尿病患者的预后

Caitlin E. Cox

October 03, 2014

News Daily News

Majority of Stable CAD Patients Misunderstand Purpose of PCI

L.A. McKeown

October 03, 2014

News Daily News

La Prueba de la Isquemia Predice el Pronóstico de Pacientes Diabéticos con EAC Asintomática

Caitlin E. Cox

October 03, 2014

News Daily News

La Inmensa Mayoría de Pacientes con EAC Estable No Entienden el Propósito de una PCI

L.A. McKeown

October 03, 2014

News Daily News

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

Caitlin E. Cox

October 03, 2014

News Industry News

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

September 16, 2014

News Industry News

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

September 16, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Industry News

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

September 15, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

Presentation TCT 2014

Stable Angina: PCI vs CABG vs OMT

Presenter: J. Jeffrey Marshall, Thomas M Tu

September 13, 2014

News Conference News TCT 2014

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

September 13, 2014

Advertisement

La Mayoría de los Operadores siguen Escrutando Lesiones Intermedias a Pesar de las Recomendaciones en materia de FFR

Revascularization Decisions in Patients With Stable Angina and Intermediate Lesions

Real-World Study Shows Benefits of Treating Culprit Vessel Only in STEMI

Model Identifies FFR-Deferred Lesions at Increased Risk of Revascularization Within 1 Year

Restenosis at Routine Angiographic Follow-up Predicts Long-term Mortality After PCI

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

缺血检测可预示患有无症状CAD的糖尿病患者的预后

Majority of Stable CAD Patients Misunderstand Purpose of PCI

La Prueba de la Isquemia Predice el Pronóstico de Pacientes Diabéticos con EAC Asintomática

La Inmensa Mayoría de Pacientes con EAC Estable No Entienden el Propósito de una PCI

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

Stable Angina: PCI vs CABG vs OMT

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content